ADVERTISEMENT

Hartalega to launch anti-microbial gloves in Europe by H2 2018


KUALA LUMPUR: Hartalega Holdings aims to launch its anti-microbial gloves in Europe by the second half of 2018 and it is working on securing Federal Drug Administration (FDA) approval to enter the US market. 

CIMB Equities Research said on Wednesday that to encourage better take-up for this product and as a marketing strategy, the group aims to price this product more competitively with any premium in its selling price just adequate to cover the additional manufacturing costs. 

Analyst Reports , Corporate News

   

ADVERTISEMENT